Novacyt S.A. (CDI) (NCYT) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Jan 2018 07:00 AM
RNS
NOVACYT REVENUES FULL YEAR 2017
02 Jan 2018 01:30 PM
RNS
Liquidity Agreement Update and Total Voting Rights
02 Jan 2018 07:00 AM
RNS
PLACED IN TECHNOLOGY FAST 500 EMEA AWARDS
01 Dec 2017 07:00 AM
RNS
Liquidity Agreement Update and Total Voting Rights
07 Nov 2017 12:39 PM
RNS
Notification of major holdings
07 Nov 2017 07:00 AM
RNS
FOR THE SECOND YEAR RUNNING WINS FAST 50 AWARD
02 Nov 2017 07:00 AM
RNS
SETTLEMENT AND REDEMPTION OF CONVERTIBLE BONDS
01 Nov 2017 07:00 AM
RNS
ADMISSION AND FIRST DAY OF DEALINGS ON AIM

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.

Novacyt launched on LSE in 2017 under the ticker NCYT. 

Novacyt share price launched at 61p. 

UK 100